Cytoprotection in the treatment of pediatric cancer: Review of current strategies in adults and their application to children
- 1 February 1999
- journal article
- review article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 32 (2) , 124-134
- https://doi.org/10.1002/(sici)1096-911x(199902)32:2<124::aid-mpo10>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Anthracycline‐induced cardiotoxicity in children with malignanciesPediatrics International, 1997
- Cancer in children: radiotherapeutic approachesBritish Medical Bulletin, 1996
- Ifosfamide, Fanconi's syndrome, and rickets.Journal of Clinical Oncology, 1991
- Cardioxane—ICRF-187 towards anticancer drug specificity through selective toxicity reductionCancer Treatment Reviews, 1991
- Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatinCancer, 1990
- Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.Journal of Clinical Oncology, 1989
- Early anthracycline cardiotoxicityThe American Journal of Medicine, 1978
- Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in manCancer, 1978
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973